{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:07:47Z","timestamp":1775585267022,"version":"3.50.1"},"reference-count":36,"publisher":"BMJ","funder":[{"DOI":"10.13039\/501100000324","name":"Gatsby Charitable Foundation","doi-asserted-by":"publisher","award":["GAT3676"],"award-info":[{"award-number":["GAT3676"]}],"id":[{"id":"10.13039\/501100000324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,2,23]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The importance of advance care planning in parkinsonism is increasingly recognised. Existing evidence shows plans are infrequent in this population. Little is known about the details of the plans themselves and whether patient factors predict advance care planning practices. This study aimed to describe advance care planning in people with parkinsonism enrolled in the PRoactive Integrated Management and Empowerment (PRIME-UK) trial, and identify factors associated with advance care planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a cross-sectional substudy of 211 participants within the PRIME-UK randomised controlled trial, a single-centre trial that randomised 214 people with parkinsonism to receive either a novel model of care (PRIME-Parkinson care) or usual care (ISRCTN trial ID 16783200). The presence of a treatment escalation plan was used as a measure of advance care planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At the time of this study, a quarter (n=53, 25%) of participants had a treatment escalation plan. 45% of plans were created during an emergency hospital admission. 100 participants had appointed a lasting power of attorney (LPA). In adjusted regression models, increasing parkinsonism severity (OR 2.2, 95% CI 1.55 to 3.12), increasing frailty (OR 3.69, 95% CI 1.42 to 9.63) and increasing comorbidity (OR 2.51, 95% CI 1.53 to 4.14) were associated with having a treatment escalation plan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Treatment escalation plans for people with parkinsonism are frequently completed in advanced disease during emergency hospital admission. Many individuals are appointing LPAs, suggesting an interest in future planning that could be further supported by clinicians. Future research should explore interventions to improve proactive outpatient advance care planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>16783200<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-006064","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:20:17Z","timestamp":1775582417000},"page":"spcare-2025-006064","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Advance care plans in parkinsonism: cross-sectional study within a randomised controlled trial"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9378-2408","authenticated-orcid":false,"given":"Alexandra","family":"Lindsay-Perez","sequence":"first","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences Department, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences Department, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7748-6849","authenticated-orcid":false,"given":"Savannah","family":"Haworth","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences Department, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Harrison","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences Department, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Henderson","sequence":"additional","affiliation":[{"name":"Ageing and Movement Research Group, Population Health Sciences Department, University of Bristol, Bristol, UK"},{"name":"Older Peoples Unit, Royal United Hospital Bath NHS Trust, Bath, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"2026040710201312000_spcare-2025-006064v1.1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2011.11.002","article-title":"Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson\u2019s disease","volume":"314","author":"Bach","year":"2012","journal-title":"J Neurol Sci"},{"key":"2026040710201312000_spcare-2025-006064v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.01.017"},{"key":"2026040710201312000_spcare-2025-006064v1.3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026040710201312000_spcare-2025-006064v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.01.008"},{"key":"2026040710201312000_spcare-2025-006064v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2016.12.331"},{"key":"2026040710201312000_spcare-2025-006064v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2020.01.003"},{"key":"2026040710201312000_spcare-2025-006064v1.7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0891988720988917","article-title":"How Do Patients With Parkinson\u2019s Disease Approach Advance Care Planning? A UK-Based Mixed Methods Study","volume":"35","author":"Churm","year":"2022","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2026040710201312000_spcare-2025-006064v1.8","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/ene.14424","article-title":"Experiences of advance care planning in Parkinson\u2019s disease and atypical parkinsonian disorders: a mixed methods systematic review","volume":"27","author":"Nimmons","year":"2020","journal-title":"Eur J Neurol"},{"key":"2026040710201312000_spcare-2025-006064v1.9","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-019-0441-6","article-title":"Palliative care for persons with Parkinson\u2019s disease: a qualitative study on the experiences of health care professionals","volume":"18","author":"Lennaerts","year":"2019","journal-title":"BMC Palliat Care"},{"key":"2026040710201312000_spcare-2025-006064v1.10","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01157","article-title":"The Role of Palliative Care in Chronic Progressive Neurological Diseases-A Survey Amongst Neurologists in the Netherlands","volume":"9","author":"Walter","year":"2018","journal-title":"Front Neurol"},{"key":"2026040710201312000_spcare-2025-006064v1.11","unstructured":"Grose C , Thomas C , Mohamed B , et al . Advance care planning in Parkinson\u2019s disease \u2013 are we getting it right? MDS Virtual Congress; 2020"},{"key":"2026040710201312000_spcare-2025-006064v1.12","doi-asserted-by":"crossref","unstructured":"Lonsdale-Eccles E , Peters A , Richfield E . 978 Advanced care planning in patients with parkinsonian disorders. Age Ageing 2022;51. doi:10.1093\/ageing\/afac126.034","DOI":"10.1093\/ageing\/afac126.034"},{"key":"2026040710201312000_spcare-2025-006064v1.13","unstructured":"Parkinson\u2019s UK . UK Parkinson\u2019s audit. 2022."},{"key":"2026040710201312000_spcare-2025-006064v1.14","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07084-8","article-title":"Proactive and Integrated Management and Empowerment in Parkinson\u2019s Disease protocol for a randomised controlled trial (PRIME-UK) to evaluate a new model of care","volume":"24","author":"Lithander","year":"2023","journal-title":"Trials"},{"key":"2026040710201312000_spcare-2025-006064v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(92)90005-N"},{"key":"2026040710201312000_spcare-2025-006064v1.16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"2026040710201312000_spcare-2025-006064v1.17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"2026040710201312000_spcare-2025-006064v1.18","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051"},{"key":"2026040710201312000_spcare-2025-006064v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2015-000971"},{"key":"2026040710201312000_spcare-2025-006064v1.20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s41999-021-00593-2","article-title":"What factors are associated with advance care planning in community-dwelling older people? Data from TILDA","volume":"13","author":"Breslin","year":"2022","journal-title":"Eur Geriatr Med"},{"key":"2026040710201312000_spcare-2025-006064v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.10.026"},{"key":"2026040710201312000_spcare-2025-006064v1.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-020-01801-7","article-title":"A scoping review of the Clinical Frailty Scale","volume":"20","author":"Church","year":"2020","journal-title":"BMC Geriatr"},{"key":"2026040710201312000_spcare-2025-006064v1.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01935.x"},{"key":"2026040710201312000_spcare-2025-006064v1.24","unstructured":"StataCorp . Stata statistical software: release 18.0. College Station, TX StataCorp LLC; 2023."},{"key":"2026040710201312000_spcare-2025-006064v1.25","unstructured":"National Institute for Health and Care Excellence . NICE guideline NG71: parkinson\u2019s disease in adults. 2017."},{"key":"2026040710201312000_spcare-2025-006064v1.26","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae046","article-title":"Delirium is more common and associated with worse outcomes in Parkinson\u2019s disease compared to older adult controls: results of two prospective longitudinal cohort studies","volume":"53","author":"Gerakios","year":"2024","journal-title":"Age Ageing"},{"key":"2026040710201312000_spcare-2025-006064v1.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjfa.2025.100073","article-title":"The interrelationship of frailty, multimorbidity and disability in Parkinson\u2019s disease: PRIME-UK cross-sectional study","volume":"14","author":"Tenison","year":"2025","journal-title":"J Frailty Aging"},{"key":"2026040710201312000_spcare-2025-006064v1.28","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1629-x"},{"key":"2026040710201312000_spcare-2025-006064v1.29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ageing\/afaa104","article-title":"Frailty status predicts futility of cardiopulmonary resuscitation in older adults","volume":"50","author":"Ibitoye","year":"2021","journal-title":"Age Ageing"},{"key":"2026040710201312000_spcare-2025-006064v1.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07404-9"},{"key":"2026040710201312000_spcare-2025-006064v1.31","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27177"},{"key":"2026040710201312000_spcare-2025-006064v1.32","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/mds.28730","article-title":"Prognostic Modeling of Parkinson\u2019s Disease Progression Using Early Longitudinal Patterns of Change","volume":"36","author":"Ren","year":"2021","journal-title":"Mov Disord"},{"key":"2026040710201312000_spcare-2025-006064v1.33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/mdc3.14215","article-title":"Validation of a 5\u2010Year Prognostic Model for Parkinson\u2019s Disease","volume":"11","author":"Ribeiro","year":"2024","journal-title":"Movement Disord Clin Pract"},{"key":"2026040710201312000_spcare-2025-006064v1.34","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000233"},{"key":"2026040710201312000_spcare-2025-006064v1.35","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-017-0016-2","article-title":"Palliative care for Parkinson\u2019s disease: suggestions from a council of patient and carepartners","volume":"3","author":"Hall","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"2026040710201312000_spcare-2025-006064v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.08.025"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-006064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:20:26Z","timestamp":1775582426000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-006064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":36,"alternative-id":["10.1136\/spcare-2025-006064"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-006064","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]}}}